所在位置: 人才队伍 >> 研究人员 >>
  • 张晶

副教授,医药生物技术国家重点实验室 

地址:南京市栖霞区仙林大道163号,210023

邮箱:jzhang08@nju.edu.cn









研究领域


肿瘤发生发展的机制研究及抗肿瘤靶点研究



工作经历


2009-至今,南京大学生命科学学院副教授,硕士生导师

2011-2012,芝加哥大学医学院访问学者

2004-2009,南京大学生命科学学院讲师



荣誉奖励


2019,南京大学本科生实践教学优秀指导教师



学术任职


2019-2023,江苏省免疫学会理事




代表性成果

[1] Zhang X, Song L, Li L, Zhu B, Huo L, Hu Z, Wang X, Wang J, Gao M, Zhang J*, Hua Z*. Phosphatidylserine externalized on the colonic capillaries as a novel pharmacological target for IBD therapy. Signal Transduct Target Ther. 2021;6(1):235. 

[2]  Zhang X, Hu Z, Wang X, Li L, Zhu B, Lin X, Zhang J*, Hua Z*. ANXA10 promotes melanoma metastasis by suppressing E3 ligase TRIM41-directed PKD1 degradation. Cancer Lett. 2021;519:237-249.  

[3]  Li H, Zhou T, Zhang Y, Jiang H, Zhang J*, Hua Z*. RuvBL1 Maintains Resistance to TRAIL-Induced Apoptosis by Suppressing c-Jun/AP-1 Activity in Non-Small Cell Lung Cancer. Front Oncol. 2021 Jun 7;11:679243.

[4]  Hu Z, Li L, Zhu B, Huang Y, Wang X, Lin X, Li M, Xu P, Zhang X, Zhang J*, Hua Z*.Annexin A5 is essential for PKCu translocation during T-cell Activation. J Biol Chem. 2020; 295(41): 14214-14221. 

[5]  Zhang X, Huo L, Song L, Hu Z, Wang X, Han Y, Wang Y, Xu P, Zhang J* and Hua Z*. Dominant Negative FADD/MORT1 Inhibits the Development of Intestinal Intraepithelial Lymphocytes With a Marked Defect on CD8αα+TCRγδ+ T Cells. Front. Immunol.,2018; 9:2038. 

[6] Zhang J*, Jiang HY, Zhang LK, Xu WL, Qiao YT, Zhu XG, Liu W, Zheng QQ, Hua ZC*. C-FLIPL Modulated Wnt/β-Catenin Activation via Association with TIP49 Protein. J Biol Chem. 2017;292(6):2132-2142.


团队风采